BlueSky Immunotherapies GmbH
PrivateLast Round
Grant
Nov 1, 2022
Total Funding Raised
$430,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
BlueSky Immunotherapies GmbH is a biotechnology company that develops next-generation immunotherapies using a proprietary interferon-inducing viral vector technology platform for the treatment of cancer and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BlueSky Immunotherapies GmbH Comparables
Compare BlueSky Immunotherapies GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nykode Therapeutics | 77% | |
| PDS Biotechnology Corp | 76% | |
| Hookipa Pharma | 75% | |
BlueSky Immunotherapies GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 1, 2022 |
BlueSky Immunotherapies GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| FFG Austrian Research Promotion Agency | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors increased 166% MoM.
- Apr 2, 2026
Monthly visitors increased 66% MoM.
BlueSky Immunotherapies GmbH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BlueSky Immunotherapies GmbH's valuation, stock price, and market status.